Tag Archives: EVHC

best website for stocks

On Wednesday, our Under the Radar Moversnewsletter suggested small cap energy technology stock Tesco Corporation (NASDAQ: TESO):

We’ve had to zoom way out on the chart of Tesco, just to illustrate what’s going on here in the bigger picture. As you can see, TESO shares are working their way out of a major setback from 2015. Over the course of 2016 we saw a string of higher lows as the stock did its best to stop the bleeding and lay the groundwork for a recovery move. It’s only been within the last few weeks, however, we started to see TESO test the waters of higher highs

This is one of those trades that we’re taking on as a short-term position, but knowing full well it could turn into a long-term holding. There’s a ton of room to recover here. Tesco was trading above $20.00 in late-2014.

best website for stocks: InterCloud Systems, Inc(ICLD)

Advisors’ Opinion:

  • [By Monica Gerson]

    InterCloud Systems Inc (NASDAQ: ICLD) is expected to post a quarterly loss at $0.14 per share on revenue of $24.00 million.

    Posted-In: Earnings scheduleEarnings News Pre-Market Outlook Markets

best website for stocks: Primo Water Corporation(PRMW)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows Sodastream International heading back up to previous highs while large cap Monster Beverage Corp (NASDAQ: MNST) has been range bound the last two years and small cap Primo Water Corporation (NASDAQ: PRMW)has been in a strong uptrend for the past few years with performance perhaps leveling off:

  • [By Peter Graham]

    A long term performance chart shows Sodastream International underperforming, but doing better last yearwhile the outperformance of large cap Monster Beverage Corp (NASDAQ: MNST) has leveled off and small cap Primo Water Corporation (NASDAQ: PRMW)has been in a strong uptrend for the past two years:

  • [By Peter Graham]

    A long term performance chart shows Sodastream International drifting higher while large cap Monster Beverage Corp (NASDAQ: MNST) has been range bound for almost three years and small cap Primo Water Corporation (NASDAQ: PRMW)has been in a strong uptrend for the past few years with that performancesomewhat leveling off:

best website for stocks: Netease.com Inc.(NTES)

Advisors’ Opinion:

  • [By Joe Tenebruso]

    Shares ofNetEase (NASDAQ:NTES)popped 20.1% last month, according to data provided byS&P Global Market Intelligence, as the Chinese internet technology company’s strong fourth-quarter earnings report was applauded by investors.

  • [By Sreekanth Anasa]

    Shares of Hangzhou, China-based NetEase Inc (NASDAQ:NTES)popped 14% in the Feb 16th trading session after the company reported stellar Q4 and full-year 2016 earnings on Feb 15th after market close. The Chinese online gaming giant delivered an EPS of $4.30 on revenues of $1.74B beating EPS estimates by $0.86 and revenue estimates by $16oM. NetEase’s revenue grew by an impressive 53.1% YoY for Q4 and 67.7% for the full year 2016. On the back of these strong numbers, NTES stock closed at an all-time high of $298.73 in yesterday’s trading session. NTES stock might have gone up very high too soon. There could be a correction around the corner but still NTES stock is a great long-term proposition with much more upside left. Here’s why.

best website for stocks: Envision Healthcare Holdings, Inc.(EVHC)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Even on a day like today, somebody had to be the worst performer in the S&P 500, and today that somebody is Envision Healthcare (EVHC), which missed earnings forecasts last night.

  • [By Paul Ausick]

    Envision Healthcare Corp. (NYSE: EVHC) dropped about 9.3% Tuesday to post a new 52-week low of $43.22 after closing Monday at $47.67. The 52-week high is $74.75. Volume of around 10 million shares traded was about six times the daily average. The company had no specific news.

  • [By Lisa Levin]

    Envision Healthcare Holdings Inc (NYSE: EVHC) shares shot up 211 percent to $70.15. Envision Healthcare and Amsurg Corp (NASDAQ: AMSG) reported the completion of their merger.

Top 10 Medical Stocks To Buy Right Now

Despite staggering increases in drug prices, Americans still aren’t living as long as those in other countries. And the worst part is they’re paying more, too…

One out of every four Americans reported that the cost of healthcare is their primary concern right now, according to a January 2017 Monmouth University poll. In fact, anxiety about paying medical bills now outpaces job and unemployment concerns, as well as worries about paying everyday household bills.

And it’s no wonder: In August, prices for medicine, doctor’s appointments, and health insurance rose at rates not seen since 1984.

Drug costs, in particular, are growing by double and triple digits each year. Back in October 2016, The Fiscal Times reported that specialty drug prices grew 18.9% and are projected to increase another 18.7% this year. Additionally, it reported that generic drug prices are expected to increase another 11% this year after already going up 11.3% in 2016.

Top 10 Medical Stocks To Buy Right Now: Envision Healthcare Holdings, Inc.(EVHC)

Advisors’ Opinion:

  • [By Paul Ausick]

    Envision Healthcare Corp. (NYSE: EVHC) dropped about 9.3% Tuesday to post a new 52-week low of $43.22 after closing Monday at $47.67. The 52-week high is $74.75. Volume of around 10 million shares traded was about six times the daily average. The company had no specific news.

  • [By Lisa Levin]

    Envision Healthcare Holdings Inc (NYSE: EVHC) shares shot up 211 percent to $70.15. Envision Healthcare and Amsurg Corp (NASDAQ: AMSG) reported the completion of their merger.

  • [By Ben Levisohn]

    Even on a day like today, somebody had to be the worst performer in the S&P 500, and today that somebody is Envision Healthcare (EVHC), which missed earnings forecasts last night.

Top 10 Medical Stocks To Buy Right Now: Nobilis Health Corp.(HLTH)

Advisors’ Opinion:

  • [By Monica Gerson]

    Nobilis Health Corp (NYSE: HLTH) is expected to report its quarterly earnings at $0.19 per share on revenue of $91.92 million.

    Avid Technology, Inc. (NASDAQ: AVID) is estimated to post its quarterly earnings at $0.36 per share on revenue of $144.02 million.

Top 10 Medical Stocks To Buy Right Now: iShares PHLX SOX Semiconductor Sector Index Fund(SOXX)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows Marvell Technology Group giving investors and traders a bit of a roller-coaster ride while peerSTMicroelectronics NV (NYSE: STM) and ETF benchmarks SPDR S&P Semiconductor ETF (NYSEARCA: XSD) and iShares PHLX SOX Semiconductor Sector (NASDAQ: SOXX) really took off last year:

  • [By Peter Graham]

    A long term performance chart shows Marvell Technology Group under performingpeersSTMicroelectronics NV (NYSE: STM) and ETF benchmarks SPDR S&P Semiconductor ETF (NYSEARCA: XSD) and iShares PHLX SOX Semiconductor Sector (NASDAQ: SOXX)will all taking offlast year:

  • [By Peter Graham]

    A long term performance chart shows Marvell Technology Group peaking in early 2015 while peerSTMicroelectronics NV (NYSE: STM) hasnt performed much better and ETF benchmarks SPDR S&P Semiconductor ETF (NYSEARCA: XSD) and iShares PHLX SOX Semiconductor Sector (NASDAQ: SOXX) have performed better:

  • [By Peter Graham]

    A long term performance chart shows Marvell Technology Group along with peersSTMicroelectronics NV (NYSE: STM) and ETF benchmarks SPDR S&P Semiconductor ETF (NYSEARCA: XSD) and iShares PHLX SOX Semiconductor Sector (NASDAQ: SOXX)all taking offlast year albeit MRVL has underperformed ETF benchmarks:

Top 10 Medical Stocks To Buy Right Now: Orion Marine Group Inc(ORN)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows small caps Great Lakes Dredge & Dock Corporation andLayne Christensen Company (NASDAQ: LAYN) underperforming, but possibly recovering while Orion Group Holdings (NYSE: ORN) had a clear reversal early last year:

Top 10 Medical Stocks To Buy Right Now: United Microelectronics Corporation(UMC)

Advisors’ Opinion:

  • [By Ashraf Eassa]

    United Microelectronics (NYSE:UMC), for example, has said that it expects to begin “commercial production” of a 14-nanometer technology “by the second half of 2017,” per EETimes.

Top 10 Medical Stocks To Buy Right Now: Polo Ralph Lauren Corporation(RL)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Hanesbrands was just one of many retail companies that got shellacked this week. Under Armour (UAA) tumbled 29% after missing earnings forecasts and cutting its guidance, while Deckers Outdoor (DECK) plunged 21% after its earnings missed the Street consensus, and Ralph Lauren (RL) plummeted 13% after its CEO stepped down.

  • [By Casey Wilson]

    Ralph Lauren Corp. (NYSE: RL) just became the latest company to fall victim to the “Retail Ice Age.”

    The 50-year-old American icon announced it shuttered its flagship store at Fifth Avenue and 55th Street in New York City on Tuesday (April 4). It will also close 50 other retail locations by the end of the fiscal year.

  • [By Johanna Bennett]

    Times are tough for Ralph Lauren (RL). Profit and sales are fallingat theiconic clothingcompany, and investors who bet on a turnaround havelost their shirts on the stock. Adding to its troubles,CEO StefanLarsson is departingfollowing a creative clash with the companys namesake and founder.

    Pessimism, meanwhile, appears to be on the rise.

    According to a report by the financial analytics company S3 Partners, short interest in Ralph Lauren has risen since the start of the year, hitting historical levels. And while that short position is expected to keep expanding, bearish sentiments could turn on a dime.

    Ihor Dusaniwsky at S3 Partners writes:

    RL short interest levels, already at historical highs today, should continue to grow if the recent trend continues, but having made almost 23% in 2016 and 14% in 2017, short sellers may be quick to cover their positions and lock in profits if RLs stock price turns against them.

    Short interest in Ralph Lauren fell in 2016 as the stock price fella nd shorts covered positions, netting a return of 22.6%. So far this year, however, the short position as increased $226 million, or 38% to $815 million as of this morning, according to the S3 report.

    Its a profitable day for those short sellers. Todays 11% decline Ralph Laurens stock price on an $815 million short position has added $90 million to the short sellers collective bottom line.

    Ralph Lauren is down 11.5% in recent market actions to $77.26 a after earlier falling as low as $76.86 a share. Thats the lowest price for the stock since 2010.

Top 10 Medical Stocks To Buy Right Now: Fitbit, Inc.(FIT)

Advisors’ Opinion:

  • [By Demitrios Kalogeropoulos]

    With the benefit of hindsight, it’s clear that the better recent stock buy in the wearables space has been GPS device specialist Garmin (NASDAQ:GRMN) over former market darlingFitbit (NYSE:FIT). It turns out that Garmin’s diverse product line helped it weather collapsing sales in its core automotive division. Targeted innovation bets by Fitbit management, on the other hand, failed to hit the sweet spot of consumer demand amid rising competitive threats.

  • [By James E. Brumley]

    The rise and fall of Fitbit Inc (NYSE:FIT) – the company and the stock – was largely in step with an incredible buzz stemming from the introduction of the company’s wares followed by the revelation that the wrist-worn devices don’t always take accurate pulse rates. The whole matter has raised one overarching question….what will it take for any company to get cardiac monitoring wearables right? To that end, a couple of different articles on the issue of remote heart monitoring that are worth passing along.

  • [By Leo Sun]

    Many investors who watched Fitbit (NYSE:FIT) and GoPro (NASDAQ:GPRO) crash and burn may believe that demand for wearable devices — like fitness trackers and action cameras — is fading. Indeed, earlier estimates for these markets were far too bullish.

  • [By James E. Brumley]

    While the economy’s natural — and recurring — cycles favor different kinds of stocks at different times, not every great trend is necessarily a cyclical one. Sometimes, a trend is rooted in a technological development that changes cultural norms. The advent of the smartphone, for example, has made constant connectivity to the world around part of how we live our daily lives.

    These mega-trends present tremendous opportunities for investors too, provided they’re savvy enough to see them coming and play them the right way.

    One such mega-trend newly underway right now is the proliferation of wearables… devices that meld clothing (often a wrist-worn device) and technology to perform a function that couldn’t be performed otherwise. Much of the same technology that made the smartphone possible are now ushering in wearables.

    It’s not been a smooth beginning. however.

    While the buzz was strong and expectations reached a peak two years ago when Fitbit Inc (NYSE:FIT) was all the rage and in the wake of its IPO, the company’s growth wasn’t to be sustained. The company is struggling to muster any growth now, and FIT shares have fallen to a tenth of their value seen in late-2015, when the euphoria was strongest.

    Fitbit’s slowdown has been mirrored by other companies in the space. The wearables market only grew 3.1% in Q3 of 2016.

    On the flipside, while the debacle of Fitbit — the wearable industry’s iconic company — has been a painful, it’s also been a learning experience. And, it’s not as if the slowdown is unfurling without the wearables market never reaching a respectable size. International Data Corporation estimates were 23 million ‘wearables’ delivered in the third quarter of last year alone.

    Moreover, the fizzling of the market hasn’t turned into a reason to swear off wearables as an investment opportunity… quite the opposite, actually. It’s just now become considerably clearer what consumers want an

  • [By Paul Ausick]

    Fitbit Inc. (NYSE: FIT) dropped about 3.3% on Thursday to record a new 52-week low of $5.62. The stock closed at $5.81 on Wednesday. Volume was about 35% below the daily average of around 11.6 million shares. The company had no news, but the ripples are still spreading from the charges leveled by competitor Jawbone over Fitbit’s theft of trade secrets.

Top 10 Medical Stocks To Buy Right Now: Amgen Inc.(AMGN)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Biotech stocks have been particularly unloved during the past year, with the iShares Nasdaq Biotech Index ETF (IBB) gaining just 7% to the S&P 500′s 20% rise. Today, however, Amgen (AMGN) is getting a lot of love from the market after releasing Street beating earnings and reporting that its anti-cholesterol drug reduced heart attacks.

  • [By Maxx Chatsko]

    Shares of Radius Health (NASDAQ:RDUS) rose over 20% Monday morning after Amgen (NASDAQ:AMGN) announced worrisome complications were discovered during a phase 3 trial for its osteoporosis drug candidate, Evenity. While the drug candidate met its primary endpoint in a more than 4,000-patient phase 3 study, a high rate of serious heart-related side effects were discovered. The drug was previously expected to gain marketing approval from the U.S. Food and Drug Administration in July, but that decision will now be delayed by up to a year or more, if the drug is approved at all.

  • [By Ben Levisohn]

    Amgen (AMGN) has tumbled 3.6% to $158.65 after beating earnings forecasts but missing on sales.

    Buffalo Wild Wings (BWLD) has dropped 3% to $157.51 after its earnings fell short of the Street consensus.

  • [By WWW.THESTREET.COM]

    Finally on Friday, Tiffany (TIF) reports, and Cramer is betting on positive news now that the company has an activist involved. He was also bullish on Amgen’s (AMGN) analyst meeting, saying investors should use any market weakness earlier in the week to buy.

  • [By Ben Levisohn]

    After years of rising and falling in tandem, the biotech sector is all about stock picking now. Credit Suisse analyst Alethia Young and team, for instance, upgraded Regeneron Pharmaceuticals (REGN), and added Celgene (CELG) to its Focus List today. But Amgen (AMGN) wasn’t so lucky as Young cut it to Neutral from Outperform. She explains why:

  • [By Keith Speights]

    Investors have turned to the pharmaceutical industry for solid dividend stocks for a long time. However, biotechs typically weren’t high on the list when it came to dividends. Over the past few years, though, Amgen, Inc. (NASDAQ:AMGN) and Gilead Sciences, Inc. (NASDAQ:GILD) have risen in prominence as attractive alternatives for dividend-seeking investors.

Top 10 Medical Stocks To Buy Right Now: Proteon Therapeutics, Inc.(PRTO)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Proteon Therapeutics Inc (NASDAQ: PRTO) got a boost, shooting up 31 percent to $1.70 after the company disclosed that it has received the FDA Breakthrough Therapy designation for Vonapanitase. Proteon Therapeutics posted a narrower-than-expected quarterly loss.

Top 10 Medical Stocks To Buy Right Now: ePlus Inc.(PLUS)

Advisors’ Opinion:

  • [By Monica Gerson]

    ePlus Inc. (NASDAQ: PLUS) is estimated to post its quarterly earnings at $1.21 per share on revenue of $284.62 million.

    Tilly’s Inc (NYSE: TLYS) is expected to post a quarterly loss at $0.07 per share on revenue of $119.93 million.

wall street stock market

Tesla’s stock was up $20 to an all-time high of $298.52 on Monday which gave the company a market cap of $48.7 billion and the shares are up another $5 today to break $300. This pushed Tesla’s market cap higher than Ford’s $45.5 billion and is closing in on GM’s $51.2 billion.

There were what I’d call two and a half reasons for Tesla’s stock price to pop on Monday. The top two were a short squeeze and a bullish note from Morgan Stanley and the half reason was the company reporting its March quarter deliveries and production which were a bit better than expected.

Tesla Motors unveils the new lower-priced Model 3 sedan at the Tesla Motors design studio in Hawthorne, Calif. (AP Photo/Justin Pritchard)

Shorts are taking it in the shorts

wall street stock market: Maxwell Technologies, Inc.(MXWL)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Maxwell Technologies Inc. (NASDAQ: MXWL) were down 15 percent to $5.34. Maxwell reported amended terms for deal with Viex Capital and announced a proposed offering of $50 million convertible senior notes due 2022.

  • [By Monica Gerson]

    Maxwell Technologies (NASDAQ: MXWL) surged 9.20% to $10.21. The volume of Maxwell Technologies shares traded was 325% higher than normal. Maxwell’s trailing-twelve-month revenue is $190.57 million.

  • [By Jim Robertson]

    On Tuesday, our Under the Radar Moversnewsletter suggestedgoing long on small cap energy storage and power delivery stock Maxwell Technologies (NASDAQ: MXWL):

wall street stock market: Portola Pharmaceuticals, Inc.(PTLA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Portola Pharmaceuticals Inc (NASDAQ: PTLA) shares dropped 23 percent to $21.92 after announcing Phase III Betrixaban results.

    Shares of Spark Energy Inc (NASDAQ: SPKE) were down 16 percent to $20.43. Spark Energy reported Q4 GAAP EPS of $(0.01) and adjusted EBITDA of $16.3 million.

  • [By Lisa Levin]

    Portola Pharmaceuticals Inc (NASDAQ: PTLA) shares dropped 30 percent to $20.08 after announcing Phase III Betrixaban results.

    Shares of Spark Energy Inc (NASDAQ: SPKE) were down 14 percent to $20.96. Spark Energy reported Q4 GAAP EPS of $(0.01) and adjusted EBITDA of $16.3 million.

  • [By Todd Campbell]

    Portola Pharmaceuticals’ (NASDAQ:PTLA)could have two commercial-stage drugs on the market next year, but turning them into top-sellers will require a lot of money. Is Portola Pharmaceuticals’ balance sheet flush enough with cash to get its drugs across the finish line?

wall street stock market: Sagent Pharmaceuticals Inc.(SGNT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Sagent Pharmaceuticals Inc (NASDAQ: SGNT) got a boost, shooting up 40 percent to $21.65 as the company agreed to be acquired by Nichi-Iko Pharmaceutical for $21.75 per share. RBC Capital downgraded Sagent Pharmaceuticals from Outperform to Sector Perform.

wall street stock market: Envision Healthcare Holdings, Inc.(EVHC)

Advisors’ Opinion:

  • [By Lisa Levin]

    Envision Healthcare Holdings Inc (NYSE: EVHC) shares shot up 211 percent to $70.15. Envision Healthcare and Amsurg Corp (NASDAQ: AMSG) reported the completion of their merger.

  • [By Paul Ausick]

    Envision Healthcare Corp. (NYSE: EVHC) dropped about 9.3% Tuesday to post a new 52-week low of $43.22 after closing Monday at $47.67. The 52-week high is $74.75. Volume of around 10 million shares traded was about six times the daily average. The company had no specific news.

  • [By Ben Levisohn]

    Even on a day like today, somebody had to be the worst performer in the S&P 500, and today that somebody is Envision Healthcare (EVHC), which missed earnings forecasts last night.

wall street stock market: Constellation Brands Inc(STZ)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Constellation Brands (STZ) has rallied 4.7% to $169 after beating earnings forecasts and offering optimistic guidance.

    Greenbrier Cos. (GBX) has advanced 2.1% to $48.25 after getting upgraded to Buy from Neutral at BofA Merrill Lynch.

  • [By WWW.THESTREET.COM]

    Then on Thursday, Constellation Brands (STZ) reports, and as we learned yesterday, this is Cramer’s favorite liquor stock. Also on Thursday, earnings from Nike (NKE) , a battleground Cramer said he’s steering clear of, and Micron Technology (MU) , which will likely fall no matter how good its quarter.

  • [By Rich Duprey]

    It’s not all bad news, as brewers such as Lagunitas and Dogfish Head, among others, were up by double-digit percentages. Constellation Brands (NYSE:STZ) also surged, and though much of that increase might be attributable to its imported Corona brands, it also has its Ballast Point craft brand to thank, as it’s been living up to its reputation as the fastest-growing craft beer.

  • [By ]

    Earlier this quarter, I told you how alcohol distributor Constellation Brands Inc. (NYSE:STZ) acquired a 10% stake in Canadian medical marijuana firm Canopy Growth Corp. (TSE:WEED). A major alcohol distributor buying a marijuana company would have been unfathomable just a few years ago. But with legalization gaining steam nationwide, this deal is shaping up to be one of many to come in the industry.

  • [By WWW.THESTREET.COM]

    Is it time to crown a new king of beers? After speaking with Constellation Brands (STZ) CEO on Thursday night’s show, Cramer said it was time to take a fresh look at the beer sector to see if a reshuffling is in order.

  • [By Craig Jones]

    Najarian also noticed big upside call options buying in Constellation Brands, Inc. (NYSE: STZ). Around 5,000 contracts of the January 240 calls were traded and he decided to follow the trade. He added that he also likes Wal-Mart Stores Inc (NYSE: WMT) for upside calls buying.

wall street stock market: Cott Corporation(COT)

Advisors’ Opinion:

  • [By Dan Moskowitz]

    Cott (NYSE: COT  ) produces and sells over 200 different types of beverages in over 50 countries, and it implements a highly effective strategy. Cott is what is known as a Fast Follower, which makes it unique to other beverage companies.

Hot High Tech Stocks To Watch Right Now

Last week ended with a string of results from some of the biggest companies in the tech sector. Positive results continued with earnings beats from Amazon.com, Inc. (NASDAQ: AMZN), Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL), and Microsoft Corporation (NASDAQ: MSFT). AMZN and GOOG also beat revenue estimates, but MSFT came up shy of Wall Street’s top-line estimates. Tech earnings continue this week with Apple Inc. (NASDAQ: AAPL) reporting fiscal Q2 results after market close tomorrow. 

AAPL is expected to report earnings of $2.01 per share, up from $1.90 in the same period last year, on revenue of $52.61 billion, according to consensus third-party analyst estimates. In the last quarter, AAPL reported all-time record quarterly revenue on strong holiday results, with international sales accounting for 64% of the quarter’s revenue, according to its earnings press release.

The big focus this quarter is on the company’s flagship smartphone products. iPhone sales are expected to increase 4.3% from a year ago, according to Wall Street estimates. In the last quarter, AAPL benefited from a rise in average selling prices, jumping to $695 from $619 in fiscal Q4. The company attributed the increase to a “very strong product mix and the amazing success of iPhone 7 Plus” on its earnings call.

Hot High Tech Stocks To Watch Right Now: Envision Healthcare Holdings, Inc.(EVHC)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Even on a day like today, somebody had to be the worst performer in the S&P 500, and today that somebody is Envision Healthcare (EVHC), which missed earnings forecasts last night.

  • [By Lisa Levin]

    Envision Healthcare Holdings Inc (NYSE: EVHC) shares shot up 211 percent to $70.15. Envision Healthcare and Amsurg Corp (NASDAQ: AMSG) reported the completion of their merger.

  • [By Paul Ausick]

    Envision Healthcare Corp. (NYSE: EVHC) dropped about 9.3% Tuesday to post a new 52-week low of $43.22 after closing Monday at $47.67. The 52-week high is $74.75. Volume of around 10 million shares traded was about six times the daily average. The company had no specific news.

Hot High Tech Stocks To Watch Right Now: Ashford Hospitality Trust Inc(AHT)

Advisors’ Opinion:

  • [By Lisa Levin] Related AHT 25 Biggest Mid-Day Gainers For Friday Mid-Day Market Update: Hortonworks Drops Following Weak Results; Freshpet Shares Spike Higher Ashford Hospitality Trust's (AHT) CEO Montgomery Bennet on Q2 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related NEWS Mid-Morning Market Update: Markets Open Higher; Micron To Lower Jobs Mid-Morning Market Update: Markets Open Lower; Broadcom Profit Beats Expectations NewStar Financial's (NEWS) CEO Tim Conway on Q2 2016 Results – Earnings Call Transcript (Seeking Alpha)

     

Hot High Tech Stocks To Watch Right Now: Allscripts Healthcare Solutions, Inc.(MDRX)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    Goldman Sachs (NYSE: GS) has at least one billion reasons to hope President Trump’s paring back of Dodd-Frank will include the Volcker Rule: Link

    ECONOMIC DATA
    10:30 a.m. Dallas Fed Manufacturing Business Index
    11:30 a.m. 6-Month Bill Auction
    11:30 a.m. 3-Month Bill Auction
    1 p.m. 2-Year Note Auction
    1:15 p.m. Chicago Fed President Evans Speaks
    6:30 p.m. FOMC Member Kaplan Speaks
    ANALYST RATINGS
    Piper Jaffray upgraded Best Buy Co (NYSE: BBY) from Neutral to Overweight
    Wells Fargo upgraded Allscripts Healthcare (NASDAQ: MDRX) from Market Perform to Outperform
    Mizuho upgraded Universal Health Service (NYSE: UHS) from Neutral to Buy
    Piper Jaffray downgraded The Michaels Companies (NASDAQ: MIK) from Overweight to Neutral
    JMP Securities downgraded KB Home (NYSE: KBH) from Market Outperform to Market Perform
    Raymond James downgraded Sierra Wireless Inc. (NASDAQ: SWIR) from Outperform to Market Perform

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here or email minutes@benzinga.com.

  • [By Monica Gerson]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Friday's regular session.

    Texas Instruments Incorporated (NASDAQ: TXN) Fri 7/1 62.0 Puts (Wkly) Sweep: 1426 @ ASK $1.24: 1426 traded vs 0 OI: Earnings 7/27 $61.86 Ref
    Allscripts Healthcare Solutions Inc (NASDAQ: MDRX) Jul16 13.0 Puts Sweep: 500 @ ASK $0.45: 500 traded vs 0 OI: Earnings 8/2 $13.07 Ref
    Intel Corporation (NASDAQ: INTC) Jul16 30.0 Puts: 7500 @ ASK $0.26: 7658 traded vs 47k OI: Earnings 7/20 $32.07 Ref
    Ares Capital Corporation (NASDAQ: ARCC) Dec16 16.0 Puts Sweep: 963 @ ASK $2.75: 974 traded vs 18 OI: Earnings 8/2 $14.45 Ref
    LinkedIn Corp (NYSE: LNKD) Aug16 115 Puts: 600 @ ASK $4.05: 615 traded vs 386 OI: $132.12 Ref

    Posted-In: Unusual Put OptionsNews Options Markets

Hot High Tech Stocks To Watch Right Now: Snap Inc. (SNAP)

Advisors’ Opinion:

  • [By Jack Delaney]

    Snap Inc. (NYSE: SNAP) is about to pay $200 million to this little-known Chinese company, and its all part of a plan to revolutionize how people share photos and videos…

  • [By Evan Niu, CFA]

    Shares of freshly public Snapchat operator Snap (NYSE:SNAP) are rebounding today, up by 7% as of 3:15 p.m. EST, after short-selling activity from the past few days mitigated.

  • [By Andrew Tonner]

    Mark Twain’s observation that “history doesn’t repeat itself, but it does rhyme,” serves as something of a cautionary tale for those thinking about investing in Snap’s (NYSE:SNAP) upcoming blockbuster IPO.

  • [By Craig Jones]

    Speaking on CNBC's "Fast Money Halftime Report", Jon Najarian said he noticed unusual bullish options activity in Snap Inc (NYSE: SNAP). Traders bought around 11,000 contracts of the August 15.50 calls in the first half of the session. They also bought the August 15 calls. Najarian has a long position in the name and he is planning to hold it for a week.

  • [By Evan Niu, CFA]

    Just days after going public, Snapchat parent company Snap (NYSE:SNAP) is already getting the cold shoulder from Wall Street. After jumping 44% and 11% on their first and second trading days, respectively, Snap shares are now down about 8% as the market starts to sober up from the IPO hype. That’s likely because a handful of Street analysts have now picked up coverage and issued ratings, and they’re not good.

  • [By Kumar Abhishek]

    Snapchat IPO has grabbed theattention of most investors and traders for some time now, especially after making a stellar debut, gaining more than 44% on the first day of listing. Though the Snap Inc (NYSE:SNAP) stock has lost the crown of the most successful IPO of the year since then to Mulesoft Inc (NYSE:MULE), the stock still continues to attract significant interest from investors and traders alike. Like most stocks whose valuations is based on ‘vision’ and ‘story’, SNAP stock remains a very contentious stock with asharp division within analysts and the investing community.

Top 10 Casino Stocks To Watch For 2018

Amaya’s stock has been on a wild roller coaster ride this year, with catalysts ranging from the CEO (David Baazov) being accused of insider trading, to takeover rumors, to failed mergers and now a formal bid by the aforementioned CEO. There have certainly been a lot of hopes and headaches, but I believe there is a strong underlining long case to be made on Amaya. I wrote a blog post about it the day before it released its Q3 earnings, my basic argument was that it is intrinsically undervalued due to market overreaction on merger discussions and there was still the possibility of a buyout by the former CEO at a significant upside. It seemed like a win-win. Well, when the earnings were released, not only were the results impressive but Baazov launched a formal bid at C$24 per share (approximately US$18) or a 30% upside from the previous Friday’s Close. Whether this private takeover succeeds or not, this stock is poised for significant long term growth.

Amaya (NASDAQ:AYA) runs the world’s largest online gaming (casino) empire in the world. It runs many valuable brand names especially in the online poker business (PokerStars and Fulltilt) but is now increasingly moving into sports betting and other online casino games. It is also the fastest growing and most well positioned to take advantage of online gambling legalization as well as the inherent scalability of the internet. This is a company which has seen its revenues increase from below US$200M just a few years ago to over US$1.2 BILLION for the trailing twelve months. Reviewing its results and its future growth prospects, it will be clear that this firm is undervalued.

Top 10 Casino Stocks To Watch For 2018: Nemaska Lithium Inc. (NMKEF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Joe is a fan of Australian-listed Galaxy Resources (GXY on the ASX), acompany with a hard-rock operation in production in Australia, a world-class brine development project (Sal de Vida) in Argentina that has a bank feasibility study on it, and a promising exploration project in Quebec, Canada, near Nemaska’s (OTCQX:NMKEF) Whabouchi project. GXY is up 60% in just the past three months.

  • [By SEEKINGALPHA.COM]

    Nemaska Lithium (OTCQX:NMKEF) provided a project update and announced a C$50 million bought deal with shares selling for C$1.05 a piece. The fresh funds will be put to work at the Whabouchi development project, which appears to be progressing well. Commercial-scale production is expected by Q1 2019.

  • [By SEEKINGALPHA.COM]

    The other producing lithium miners, and soon to be producers. I have discussed these previously in detail here, here and here. Needless to say, the top 3 producers are non-pure plays (SQM (NYSE:SQM), Albemarle (NYSE:ALB), and FMC Corp. (NYSE:FMC)). The top pure play currently producing miners are Orocobre (ASX:ORE) (OTCPK:OROCF), Tianqi Lithium (SHE:002466), Jiangxi Ganfeng Lithium, Galaxy Resources, Mineral Resources [ASX:MIN] (OTC:MALRF), and Neometals [ASX:NMT] (OTC:RRSSF). The near-term producers include Altura Mining [ASX:AJM] (OTCPK:ALTAF), Pilbara Minerals (ASX:PLS) (OTC:PILBF), Kidman Resources (ASX:KDR), Critical Elements, Nemaska Lithium (OTCQX:NMKEF) [TSX:NMX], Lithium Americas (OTCQX:LACDF) [TSX:LAC], Lithium X (OTCQX:LIXXF) (TSXV:LIX), Neo Lithium, and Bacanora Minerals (OTC:BCRMF) [TSXV:BCN], Advantage Lithium (OTCQB:AVLIF) [AAL], European Metals (OTCPK:MNTCF, ASX:EMH, AIM:EMH) and Pure Energy (OTCQB:PEMIF) [PE].

Top 10 Casino Stocks To Watch For 2018: Rockwell Automation, Inc.(ROK)

Advisors’ Opinion:

  • [By Lee Jackson]

    These companies also reported insider selling last week: Aetna Inc. (NYSE: AET), Cullen/Frost Bankers Inc. (NYSE: CFR), Rockwell Automation Inc. (NYSE: ROK), Stamps.com (NASDAQ: STMP) and Western Alliance Bancorporation (NYSE: WAL).

  • [By Paul Ausick]

    Blaming the unwillingness of its target even to discuss a buyout, Emerson Electric Co. (NYSE: EMR) on Tuesday announced that it has withdrawn its unsolicited offer to acquire Rockwell Automation Inc. (NYSE: ROK) for $225 a share in a deal valued at nearly $30 billion.

  • [By Ben Levisohn]

    Bernstein’s Steven Winoker looks back at 2016 for the industrial stocks he covers–Ingersoll-Rand (IR), Rockwell Automation (ROK), Eaton (ETN), and General Electric (GE) among them–and contemplates what 2017 might hold:

Top 10 Casino Stocks To Watch For 2018: First Majestic Silver Corp.(AG)

Advisors’ Opinion:

  • [By Lisa Levin] Related CXW Trump Or Clinton: Who Would Create More Jobs? The 2016 Economics Nobel Prize Winner's Case Against Private Prisons: Contracts Are The Key Wall Street Breakfast: Trump Takes The White House (Seeking Alpha)
    Related SAEX 20 Biggest Mid-Day Losers For Friday 22 Stocks Moving In Friday's Pre-Market Session SAExploration wins $35M seismic data deal (Seeking Alpha)
    Gainers
    Corrections Corp Of America (NYSE: CXW) shares rose 16.3 percent to $16.50 in pre-market trading following Donald Trump's victory.
    SAExploration Holdings, Inc. (NASDAQ: SAEX) shares rose 15.4 percent to $7.26 in pre-market trading after the company reported a new $35 million deep water ocean-bottom marine project award.
    The GEO Group Inc (NYSE: GEO) shares rose 12.9 percent to $26.95 in pre-market trading following Donald Trump's victory.
    Cloud Peak Energy Inc. (NYSE: CLD) rose 12.3 percent to $7.40 in pre-market trading after gaining 0.30 percent on Tuesday.
    Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) rose 11.7 percent to $10.35 in pre-market trading. Ariad Pharmaceuticals disclosed that its Phase 1/2 trial data on investigational drug brigatinib were published in The Lancet Oncology.
    AK Steel Holding Corporation (NYSE: AKS) rose 11.2 percent to $6.75 in pre-market trading after gaining 3.23 percent on Tuesday.
    Pretium Resources Inc (NYSE: PVG) rose 11 percent to $10.50 in pre-market trading after declining 1.66 percent on Tuesday.
    First Majestic Silver Corp (NYSE: AG) rose 9.3 percent to $8.90 in the pre-market trading session. First Majestic reported Q3 earnings of $0.07 per share on revenue of $79.3 million. Silver futures gained 2.2 percent to $18.77 an ounce.
    Dicerna Pharmaceuticals Inc (NASDAQ: DRNA) rose 9.2 percent to
  • [By Jim Robertson]

    There is no denying that some silver stocks have a problem with the problem beingthe focus on silver. On Monday, some key silver stocks like First Majestic Silver Corp (NYSE: AG) along with solver benchmark the iShares Silver Trust ETF (NYSEARCA: SLV) saw sharper than normal selloffs on an otherwise short trading day. The problem for investors in First Majestic Silver Corp is that its probably the closest thing to a pure play silver stock out there as most other silver miners have long since made aneffort to diversify into gold and other preciousmetals in case silver prices fall off.

Top 10 Casino Stocks To Watch For 2018: Embraer-Empresa Brasileira de Aeronautica(ERJ)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, industrials shares fell by 0.12 percent. Meanwhile, top losers in the sector included Stericycle Inc (NASDAQ: SRCL), down 17 percent, and Embraer SA (ADR) (NYSE: ERJ), down 13 percent.

Top 10 Casino Stocks To Watch For 2018: Euronet Worldwide Inc.(EEFT)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap Blackhawk Network Holdingshas movedboth sidewaysor slowly upward after its IPO spinoff from Safeway (NYSE: SWY) whilepotential peer of Green Dot Corporation (NYSE: GDOT) is performing betterwhile Euronet Worldwide, Inc (NASDAQ: EEFT) has been a outperformer:

  • [By Peter Graham]

    Small cap Blackhawk Network Holdingshas largely moved sidewaysafter its IPO spinoff from Safeway (NYSE: SWY) whilepotential peer of Green Dot Corporation (NYSE: GDOT) has underperformed and Euronet Worldwide, Inc (NASDAQ: EEFT) has outperformed:

  • [By Ben Levisohn]

    Western Union (WU) soared to the top of the S&P 500 today after MoneyGram International (MGI) received a bid from Euronet Worldwide (EEFT).

    Agence France-Presse/Getty Images

    Shares of Western Union gained 3.5% to $20.27 today, while the S&P 500 fell 0.3% to 2,365.45.MoneyGram International surged 25% to $15.77, while Euronet Worldwide advanced 0.3% to $83.22.

  • [By Peter Graham]

    Blackhawk Network Holdingshas largelymovedsidewaysor slowly upward after its IPO spinoff from Safeway (NYSE: SWY) whilepotential peers like small capGreen Dot Corporation (NYSE: GDOT) and mid capEuronet Worldwide, Inc (NASDAQ: EEFT) have beenoutperformers:

Top 10 Casino Stocks To Watch For 2018: Envision Healthcare Holdings, Inc.(EVHC)

Advisors’ Opinion:

  • [By Paul Ausick]

    Envision Healthcare Corp. (NYSE: EVHC) dropped about 9.3% Tuesday to post a new 52-week low of $43.22 after closing Monday at $47.67. The 52-week high is $74.75. Volume of around 10 million shares traded was about six times the daily average. The company had no specific news.

  • [By Lisa Levin]

    Envision Healthcare Holdings Inc (NYSE: EVHC) shares shot up 211 percent to $70.15. Envision Healthcare and Amsurg Corp (NASDAQ: AMSG) reported the completion of their merger.

  • [By Ben Levisohn]

    Even on a day like today, somebody had to be the worst performer in the S&P 500, and today that somebody is Envision Healthcare (EVHC), which missed earnings forecasts last night.

Top 10 Casino Stocks To Watch For 2018: Guidewire Software, Inc.(GWRE)

Advisors’ Opinion:

  • [By Monica Gerson]

    Guidewire Software Inc (NYSE: GWRE) is estimated to post its quarterly earnings at $0.06 per share on revenue of $92.43 million.

    Analogic Corporation (NASDAQ: ALOG) is projected to post its quarterly earnings at $0.88 per share on revenue of $127.30 million.

  • [By Peter Graham]

    A long term performance chart shows Ebix Inc actually performing well since the end of 2014 while mid cap peer Guidewire Software Inc (NYSE: GWRE) has been outperforming over a longer period of time and small cap Benefitfocus Inc (NASDAQ: BNFT) has underperformed:

Top 10 Casino Stocks To Watch For 2018: Apogee Enterprises, Inc.(APOG)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Let me introduce you to Apogee Enterprises (APOG) a company with “yuge” profit potential. Founded in 1949 and headquartered in Minneapolis, Minnesota, APOG designs and develops glass solutions for commercial buildings.

Top 10 Casino Stocks To Watch For 2018: Roche Holding AG (RHHBY)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Keytruda is also picking up indications, trading up Thursday on news of a new FDA approval in front line lung cancer treatment (not a big surprise, but there was some doubt). Some adverse news on Roche’s (OTCQX:RHHBY) I-O competitor Tecentriq in bladder cancer led IBD to publish this:

  • [By SEEKINGALPHA.COM]

    Medtronic operates both in the therapeutic and diagnostic medical markets throughout the world; the company’s varied product lines face a vast combination of competitors, ranging from large manufacturers with multiple business lines (exemplified by Johnson & Johnson) to smaller manufacturers offering a limited selection of products, like Insulet (NASDAQ:PODD). Other notable competitors include Abbott Labs (NYSE:ABT), C.R. Bard (NYSE:BCR), Baxter (NYSE:BAX), LivaNova (NASDAQ:LIVN), Roche (OTCQX:RHHBY), DexCom (NASDAQ:DXCM) and Tandem (NASDAQ:TNDM).

  • [By Ben Levisohn]

    We expect a strong 2017 performance from Keytruda in NSCLC, though revenue and EPS estimates are now 2%-7% and 5%-12% below consensus between 2017E-20E. We also expect further pressure on Keytruda in 2018, driven by share losses in first-line non-small cell lung cancer to Bristol-Myers Squibb (BMY), AstraZeneca (AZN) and Roche (RHHBY) as well as an increasing overhang from the Januvia/ Janumet patent expiries as they loom ever closer. Merck screens poorly on many valuation metrics to us and we have downgraded the shares to Underperform.

  • [By SEEKINGALPHA.COM]

    There’s still a lot to love about BMY and Opdivo, as they have the potential to be much larger. Now, notable BMY buyers could be the likes of Novartis (NYSE:NVS), Roche (OTCQX:RHHBY) or Pfizer (NYSE:PFE) – PFE has been looking to up its presence in the oncology market, and is also looking for a major purchase. BMY has a strong oncology pipeline that could work well with PFE or even Gilead (NASDAQ:GILD). GILD has an interest in oncology, and has plenty of cash for a buyout.

Top 10 Casino Stocks To Watch For 2018: Dermira, Inc.(DERM)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Current market dynamics, particularly in the SMID biotech universe, provide a plethora of opportunities for the company to augment the breadth and depth its pipeline in its core therapeutic areas, including neurology, ophthalmology and dermatology, where innovation is rife and where consolidation of some of the smaller players in the space is likely, in our view. Stocks in our SMID coverage universe that could potentially constitute future acquisition targets forAllergan include Aclaris Therapeutics (ACRS) and Dermira (DERM) (both have mid- to late-stage dermatology assets in development). We note with interest the collaboration with Heptares announced yesterday evening for the development of several M1, M4 and dual M1/M4 agonists in development for a variety of neurological diseases, including Alzheimers disease. Notwithstanding this above, larger scale transactions of course cannot be ruled out, and we note todays market commentary (Fox Business) regarding the potential sale of Valeant Pharmaceuticals International’s (VRX) Bausch & Lomb unit. It is reasonable to assume thatAllergan could be a bidder for this asset, given the companys presence in ophthalmology, as well as CEO Brent Saunders familiarity with the asset (he was the CEO prior to its sale toValeant in 2013 for $8.7bn). At the time of its sale to Valeant, B&L was generating c.$3bn in revenues and growing at a double-digit rate. Current sales of the asset are unclear due to the reporting structure of Valeant, as well as concerns regarding the companys operating/ pricing strategy.